摘要
目的探讨高压氧联合药物治疗血管性痴呆的临床疗效。方法本研究共收集合格病例103例,并随机分为两组研究组52例,对照组51例,研究组给予高压氧治疗及尼莫地平、石杉碱甲口服;对照组给予石杉碱甲片,两组均连续治疗12周。结果对照组与研究组在MoCA、ADL评分及ERPs测量均存在明显差异。结论采用高压氧及药物综合治疗对血管性痴呆患者的认知功能及日常生活能力具有良好的改善作用,减轻痴呆程度,疗效较单用药物治疗显著。
Objective To explore the clinical effect of hyperbaric oxygen combined with medicine in treatment of vascu- lar dementia. Methods Totally 103 patients were randomly divided into two groups, study group 52 cases and control group 51 cases,patients in study group used nimodipine, oral huperzine A;Control group used buperzine A, two groups were treated for 12 weeks. Results MoCA, ADL score and ERPs measure in two groups have significant difference. Conclusions Hyperbaric oxygen combined with medicine in treatment of vascular dementia can improve the cognitive function and ADL of patients, ease the moderate vascular dementia, the effect was better than use medical alone.
出处
《医药论坛杂志》
2012年第10期42-43,共2页
Journal of Medical Forum
关键词
高压氧
药物治疗
血管性痴呆
Hyperbaric oxygen
Medicine
Vascular dementia
